Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule with the chemical formula C24H23ClN2O4 and a molecular weight of approximately 438.9 g/mol. It contains an indole core substituted with an oxazole ring and a chlorophenyl group. The drug is classified as experimental and has not been approved for any indication in the US or elsewhere. There are no known clinical trials or patents associated with this molecule, and its mechanism of action as well as therapeutic targets have not been established in public databases. No information on its pharmacological activity or intended use is available from current sources.[1][7][9]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (2S)-3-(1-{[2-(2-chlorophenyl)-5-methyl-1,3-oxazol-4-yl]methyl}-1H-indol-5-yl)-2-ethoxypropanoic acid.